Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Edgar Hans Bishop


  • Director at Agilent Technologies Inc. (A), 2020-04-21
  • at Celgene Corp (CELG), 2019-11-22
  • Ceo & President at Juno Therapeutics Inc. (JUNO), 2018-03-07
  • Director at Avanir Pharmaceuticals Inc. (AVNR), 2014-02-15
  • Chief Operating Officer at Dendreon Corp (DNDN), 2011-08-02
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
JUNO $48.56 42,457 Officer, Director 2,502,429 2018-01-16 Filing
JUNO $47.69 23,003 Officer, Director 2,544,886 2018-01-16 Filing
JUNO $46.52 49,082 Officer, Director 2,567,889 2018-01-16 Filing
JUNO $45.53 89,888 Officer, Director 2,616,971 2018-01-16 Filing
JUNO $44.72 65,820 Officer, Director 2,706,859 2018-01-16 Filing